Michael Bødker Lauritzen

6PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples nursing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 05, 2026
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

|Feb 16, 2026
Selecting patients with rectal cancer for total neoadjuvant therapy based on clinical lymph node status: do we dare?

Anna Baech Slipsager, Michael Bødker Lauritzen, Laura Katrine Buskov

|Dec 01, 2025
Navigating work life after colorectal cancer: insights into work ability and functioning - a Danish follow-up study.

Pernille Pedersen, Laura S Berntsen, Annette B Bräuner

|Jan 15, 2025
The decline of male sexual activity and function after surgical treatment for rectal cancer.

Anne Thyø, Peter Christensen, Ismail Gögenur

|Aug 17, 2023
Prospective evaluation of bowel function and quality of life after colon cancer surgery - is it time for routine screening for late sequelae?

Annette Boesen Bräuner, Nicolas Avellaneda, Peter Christensen

|Feb 09, 2023
Bowel dysfunction following pelvic organ cancer: a prospective study on the treatment effect in nurse-led late sequelae clinics.

Mira Mekhael, Helene M Larsen, Michael B Lauritzen

Pageof 1